[Metabolic alkaloses in intensive care].
D000136:Acid-Base Equilibrium; D000471:Alkalosis / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D001639:Bicarbonates / Q000009:adverse effects; D001784:Blood Gas Analysis; D002021:Buffers; D002245:Carbon Dioxide / Q000097:blood; D002257:Carbonic Anhydrase Inhibitors; D004232:Diuretics / Q000009:adverse effects; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007049:Iatrogenic Disease / Q000209:etiology; D007362:Intensive Care Units; D000451:Mineralocorticoid Receptor Antagonists; D012121:Respiration, Artificial / Q000009:adverse effects; D014325:Tromethamine / Q000009:adverse effects; D014882:Water-Electrolyte Balance
D001639:Bicarbonates; D002021:Buffers; D002257:Carbonic Anhydrase Inhibitors; D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists; D014325:Tromethamine; D002245:Carbon Dioxide
Metabolische Alkalosen bei Intensivbehandlung.